Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
Adriano Lazzarin(Vita-Salute San Raffaele University), Miklos Salgo(La Roche College), Bonaventura Clotet(IrsiCaixa), Jacques Reynes(Centre Hospitalier Universitaire de Montpellier), Cynthia Wat(Roche (United Kingdom)), John Delehanty(Tris Pharma (United States)), Claude Drobnes(Tris Pharma (United States)), Mark Nelson(Chelsea and Westminster Hospital), Jean-François Delfraissy(Inserm), Keikawus Arastéh(Auguste-Viktoria-Klinik), Ralph DeMasi(Janssen (Belgium)), Les Huson(Hammersmith Hospital), David A. Cooper(UNSW Sydney), Joep M. A. Lange(University of Amsterdam), Hans-Jürgen Stellbrink(Universität Hamburg), Christine Katlama(Inserm)
Cited by 653
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k